Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE2A | O00408 | 1/20 | 0.34 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.34 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.34 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17339855 | 0.86 | HSD17B10 (0.35) | NPC1ALDH1A1TP53MAPTPKM | |
| SCHEMBL20489514 | 0.75 | ALDH1A1 (0.38) | ALDH1A1HPGD | |
| SCHEMBL178967 | 0.70 | HSD17B10 (0.39) | PDE2APDE4DPDE3APDE10ANPC1 | |
| SCHEMBL14970054 | 0.67 | HSD17B10 (0.33) | NPC1ALDH1A1TP53MAPTPKM | |
| SCHEMBL8342708 | 0.67 | HSD17B10 (0.31) | NPC1ALDH1A1TP53MAPTPKM | |
| SCHEMBL12340091 | 0.65 | KDM4E (0.37) | ALDH1A1 | |
| SCHEMBL2607126 | 0.65 | HSD17B10 (0.36) | NPC1ALDH1A1TP53MAPTPKM | |
| SCHEMBL814058 | 0.65 | HSD17B10 (0.33) | NPC1ALDH1A1TP53MAPTPKM | |
| SCHEMBL7990997 | 0.64 | USP2 (0.32) | HSD17B10 | |
| SCHEMBL23480226 | 0.62 | GAA (0.52) | PDE2APDE4DPDE3APDE10ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023109942-A1 | COMPOUND-LINKER CONSTRUCTS COMPRISING NOVEL COMPOUNDS USEFUL AS STING AGONISTS AND USES THEREOF | JACOBIO PHARMACEUTICALS CO., LTD. (CN) | 2023-06-22 | — | — | WO | disclosed |
| WO-2021113679-A1 | DIMERIC COMPOUNDS AS STING AGONISTS | MERSANA THERAPEUTICS, INC. (US) | 2021-06-10 | — | — | WO | disclosed |
| US-20180099921-A1 | MIXTURE OF POLYMERIZABLE COMPOUND AND METHOD OF PRODUCING THE SAME | ZEON CORPORATION (JP) | 2018-04-12 | — | — | US | disclosed |
| US-20170335193-A1 | POLYMERIZABLE COMPOUND, MIXTURE, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, POLYMER, OPTICAL FILM, OPTICALLY ANISOTROPIC PRODUCT, POLARIZING PLATE, FLAT PANEL DISPLAY DEVICE, ORGANIC ELECTROLUMINESCENCE DISPLAY DEVICE, AND ANTI-REFLECTION FILM | ZEON CORPORATION (JP) | 2017-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180099921-A1 | MIXTURE OF POLYMERIZABLE COMPOUND AND METHOD OF PRODUCING THE SAME | DDT, CA4, DNMT3B | PDE2A 1067/4885PDE4D 466/4885PDE3A 1005/4885 |
| US-20170335193-A1 | POLYMERIZABLE COMPOUND, MIXTURE, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, POLYMER, OPTICAL FILM, OPTICALLY ANISOTROPIC PRODUCT, POLARIZING PLATE, FLAT PANEL DISPLAY DEVICE, ORGANIC ELECTROLUMINESCENCE DISPLAY DEVICE, AND ANTI-REFLECTION FILM | NR2E3, NR3C2, NR2C2 | PDE2A 4244/4885PDE4D 4148/4885PDE3A 4291/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.